What's new? Log in Free sign up

Stryker (SYK)

Company Profile

Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.

Company profile

Ticker

SYK

Exchange

Website

www.stryker.com

CEO

Kevin Lobo

Incorporated

Location

Fiscal year end

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Surgical & Medical Instruments & Apparatus

3M • Baxter International • Boston Scientific • Becton, Dickinson And • Teleflex • Resmed • West Pharmaceutical Services • Haemonetics • Hill-Rom • Integra Lifesciences ...

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

2Hip Holdings SAS • Aimago SA • Alcott Indemnity Company • Arrinex, Inc. • Berchtold + Fritz GmbH • Berchtold Corporation • Berchtold GmbH & Co. KG • Berchtold Holding Switzerland GmbH • BioMimetic Therapeutics USA, Inc. • BioMimetic Therapeutics, LLC ...

IRS number

381239739

SYK stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$313.71

Low target

$287.00

High target

$345.00

Canaccord Genuity

Truist Securities

Latest filings (excl ownership)

View all

Conflict minerals disclosure

Submission of Matters to a Vote of Security Holders

Quarterly report

2 May 23

Stryker Reports First Quarter 2023 Operating Results

Letter from SEC

Correspondence with SEC

Letter from SEC

Correspondence with SEC

Additional proxy soliciting materials

Definitive proxy

28 Mar 23

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

Srikant M. Datar

Notice of proposed sale of securities

Andrew K Silvernail

RONDA E STRYKER

Tatum Lisa M Skeete

Sherilyn S McCoy

Allan C. Golston

Srikant M. Datar

Giovanni Caforio

Financial summary

Financial statements Chart SYK financial data

Quarter (USD)	Mar 23	Dec 22	Sep 22	Jun 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	1.67 bn	1.67 bn	1.67 bn	1.67 bn	1.67 bn	1.67 bn
Cash burn (monthly)	57.67 mm	(no burn)	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	110.36 mm	n/a	n/a	n/a	n/a	n/a
Cash remaining	1.56 bn	n/a	n/a	n/a	n/a	n/a
Runway (months of cash)	27.1	n/a	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from Stryker earnings reports.

Institutional ownership, Q1 2023

SYK institutional ownership history Ownership history

77.8% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	1648	1611	+2.3%
Opened positions	160	198	-19.2%
Closed positions	123	90	+36.7%
Increased positions	547	565	-3.2%
Reduced positions	641	576	+11.3%

13F shares	Current	Prev Q	Change
Total value	83.65 tn	73.17 tn	+14.3%
Total shares	294.83 mm	299.78 mm	-1.6%
Total puts	910.51 k	777.40 k	+17.1%
Total calls	1.54 mm	1.44 mm	+6.8%
Total put/call ratio	0.6	0.5	+9.6%

Largest owners	Shares	Value	Change
Vanguard	30.30 mm	$8.65 tn	+0.2%
BLK Blackrock	24.67 mm	$7.04 tn	+0.7%
Greenleaf Trust	19.30 mm	$5.51 tn	-1.7%
Wellington Management	16.16 mm	$4.61 tn	-5.1%
Capital Research Global Investors	16.03 mm	$4.58 tn	+13.9%
T. Rowe Price	14.32 mm	$4.08 tn	-4.3%
STT State Street	14.05 mm	$4.02 tn	-0.5%
BK Bank Of New York Mellon	6.68 mm	$1.91 tn	+1.5%
FMR	6.01 mm	$1.72 tn	+50.5%
Geode Capital Management	5.95 mm	$1.70 tn	+2.0%

Largest transactions	Shares	Bought/sold	Change
Norges Bank	0.00	-3.18 mm	EXIT
Cottage Street Advisors	11.16 k	-2.27 mm	-99.5%
FMR	6.01 mm	+2.02 mm	+50.5%
Capital Research Global Investors	16.03 mm	+1.95 mm	+13.9%
Wellington Management	16.16 mm	-872.58 k	-5.1%
Massachusetts Financial Services	2.08 mm	-825.92 k	-28.4%
BAC Bank Of America	3.58 mm	+820.88 k	+29.8%
MS Morgan Stanley	5.17 mm	-808.39 k	-13.5%
Novo Holdings A/S	0.00	-796.94 k	EXIT
JPM JPMorgan Chase & Co.	2.02 mm	+706.84 k	+53.9%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

SYK insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
18 May 23	Srikant M. Datar	Common Stock	Sell	Dispose S	No	No	286	1,000	286.00 k	5,967
10 May 23	Brainerd Mary K	Common Stock	Grant	Acquire A	No	No	0	705	0.00	5,815
10 May 23	Caforio Giovanni	Common Stock	Grant	Acquire A	No	No	0	705	0.00	2,555
10 May 23	Srikant M. Datar	Common Stock	Grant	Acquire A	No	No	0	705	0.00	6,967
10 May 23	Golston Allan C.	Common Stock	Grant	Acquire A	No	No	0	705	0.00	14,242

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

Analyst Ratings for Stryker

Argus Research Maintains Buy on Stryker, Raises Price Target to $310

Argus Research analyst David Toung maintains Stryker (NYSE:SYK) with a Buy and raises the price target from $285 to $310.

Meta Platforms, JPMorgan And 2 Other Stocks Insiders Are Selling

The Nasdaq 100 closed lower on Friday. Investors, meanwhile, focused on some notable insider trades.

$100 Invested In Stryker 10 Years Ago Would Be Worth This Much Today

10 Health Care Stocks With Whale Alerts In Today's Session

Press releases

From Benzinga Pro

Surgeons Successfully Complete First Surgical Cases Using Stryker's Q Guidance System with Cranial Guidance Software

Technology provides groundbreaking planning and guidance capabilities Stryker (NYSE:SYK), one of the world's leading medical technology companies, announced that Early Product Surveillance (EPS) cases utilizing its Q

Stryker declares a $0.75 per share quarterly dividend

Kalamazoo, Michigan, May 10, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable July 31, 2023 to shareholders of record at

Stryker completes acquisition of Cerus Endovascular

KALAMAZOO, Michigan, USA, May 2, 2023 /PRNewswire/ -- Stryker (NYSE:SYK), one of the world's leading medical technology companies, announced today that it has completed the acquisition of Cerus Endovascular Ltd., a

Stryker reports first quarter 2023 operating results

Pressure Ulcers Treatment Market Size US$ 6.9 Billion by 2028 With Growth Rate (CAGR) 5.18% | IMARC Group

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.